Galena Biopharma Market Cap:
201.89M for May 17, 2013Galena Biopharma Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 201.89M |
| May 16, 2013 | 207.71M |
| May 15, 2013 | 211.86M |
| May 14, 2013 | 208.54M |
| May 13, 2013 | 213.53M |
| May 10, 2013 | 223.50M |
| May 9, 2013 | 226.82M |
| May 8, 2013 | 225.99M |
| May 7, 2013 | 222.67M |
| May 6, 2013 | 230.14M |
| May 3, 2013 | 206.05M |
| May 2, 2013 | 201.89M |
| May 1, 2013 | 233.47M |
| April 30, 2013 | 238.45M |
| April 29, 2013 | 228.48M |
| April 26, 2013 | 211.03M |
| April 25, 2013 | 205.22M |
| April 24, 2013 | 204.39M |
| April 23, 2013 | 195.25M |
| April 22, 2013 | 192.76M |
| April 19, 2013 | 199.40M |
| April 18, 2013 | 188.60M |
| April 17, 2013 | 192.76M |
| April 16, 2013 | 194.42M |
| April 15, 2013 | 181.12M |
| April 12, 2013 | 190.26M |
| April 11, 2013 | 203.56M |
| April 10, 2013 | 191.09M |
| April 9, 2013 | 180.29M |
| April 8, 2013 | 172.82M |
| April 5, 2013 | 171.15M |
| April 4, 2013 | 169.49M |
| April 3, 2013 | 167.00M |
| April 2, 2013 | 170.32M |
| April 1, 2013 | 171.98M |
| March 28, 2013 | 174.44M |
| March 27, 2013 | 174.44M |
| March 26, 2013 | 172.78M |
| March 25, 2013 | 172.78M |
| March 22, 2013 | 160.32M |
| March 21, 2013 | 159.07M |
| March 20, 2013 | 161.98M |
| March 19, 2013 | 162.40M |
| March 18, 2013 | 167.80M |
| March 15, 2013 | 159.49M |
| March 14, 2013 | 164.06M |
| March 13, 2013 | 172.78M |
| March 12, 2013 | 177.76M |
| March 11, 2013 | 168.63M |
| March 8, 2013 | 165.43M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
GALE Market Cap Benchmarks
| Companies | |
|---|---|
| AVEO Pharmaceuticals | 156.03M |
| Achillion Pharmaceuticals | 750.24M |
| InterMune | 816.03M |
GALE Market Cap Rankings
| Overall |
58th percentile 3316 of 8002 |
| Sector |
50th percentile 324 of 650 in Healthcare |
| Industry |
58th percentile 98 of 237 in Biotechnology |
GALE Market Cap Range, Past 5 Years
| Minimum | 15.95M | Dec 19 2011 |
| Maximum | 238.45M | Apr 30 2013 |
| Average | 76.73M |